These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8761599)

  • 21. Pasteurella multocida sepsis, due to a scratch from a pet cat, in a post-chemotherapy neutropenic patient with non-Hodgkin lymphoma.
    Yokose N; Dan K
    Int J Hematol; 2007 Feb; 85(2):146-8. PubMed ID: 17321993
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospective evaluation of twice-daily cefotaxime in the treatment of hospitalized patients with severe infections.
    Keller C
    Diagn Microbiol Infect Dis; 1995; 22(1-2):159-61. PubMed ID: 7587032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cefepime and amikacin as empirical therapy in patients with febrile neutropaenia: a single-centre phase II prospective survey.
    Mebis J; Vandeplassche S; Goossens H; Berneman ZN
    Acta Clin Belg; 2009; 64(1):35-41. PubMed ID: 19317239
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cefepime monotherapy for treatment of febrile neutropenia in children.
    Ariffin H; Ai CL; Lee CL; Abdullah WA
    J Paediatr Child Health; 2006 Dec; 42(12):781-4. PubMed ID: 17096713
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Empirical cefepime monotherapy in febrile neutropenia].
    Kliasova GA
    Antibiot Khimioter; 2003; 48(7):33-7. PubMed ID: 14628577
    [No Abstract]   [Full Text] [Related]  

  • 26. Cefepime versus ceftazidime: considerations for empirical use in critically ill patients.
    Roberts JA; Webb SA; Lipman J
    Int J Antimicrob Agents; 2007 Feb; 29(2):117-28. PubMed ID: 17158033
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vancomycin-resistant enterococcal infections.
    Murray BE
    N Engl J Med; 2000 Mar; 342(10):710-21. PubMed ID: 10706902
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical and electroencephalographic assessment of cefepime during treatment of nosocomial infections in neurological patients.
    Alvarez SD; Aragon Mdel C; Moreno A; Palomares-Alonso F; Cook HJ; Cardenas G; Soto-Hernandez JL
    Cent Nerv Syst Agents Med Chem; 2011 Sep; 11(3):223-7. PubMed ID: 21919869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [3-Year experience of use of cefepime (Maxipime) for the treatment of hospital infections in a specialized surgical hospital].
    Mitrokhin SD; Avilova ND
    Antibiot Khimioter; 2004; 49(1):26-9. PubMed ID: 15164521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Piperacillin/tazobactam versus cefepime as initial empirical antimicrobial therapy in febrile neutropenic patients: a prospective randomized pilot study.
    Böhme A; Shah PM; Stille W; Hoelzer D
    Eur J Med Res; 1998 Jul; 3(7):324-30. PubMed ID: 9682028
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of cefepime versus ceftriaxone-amikacin as empirical regimens for the treatment of febrile neutropenia in acute leukemia patients.
    Borbolla JR; López-Hernández MA; González-Avante M; DeDiego J; Trueba E; Alvarado ML; Jiménez RM
    Chemotherapy; 2001; 47(5):381-4. PubMed ID: 11561142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is cefepime safe for clinical use? A Bayesian viewpoint.
    Kalil AC
    J Antimicrob Chemother; 2011 Jun; 66(6):1207-9. PubMed ID: 21471137
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The efficacy of cefepime (Maxipime) in the treatment of abdominal sepsis in surgical patients].
    Gel'fand EB; Belotserkovskiĭ BZ; Alekseeva EA; Tsedenzhapov ETs; Karabak VI; Gel'fand BR
    Antibiot Khimioter; 1999; 44(11):17-22. PubMed ID: 10629737
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Demographics, morbidity, and mortality febrile neutropenic adult patients treated with cefepime].
    Puentes GA; Quiroga C; Alvarez CA; Támara JR; Ruiz A
    Rev Chilena Infectol; 2012 Jun; 29(3):322-8. PubMed ID: 23096473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hospital infections caused by Pseudomonas aeruginosa. Significance in intensive therapy].
    Sidorenko SV; Gel'fand EB; Mamontova OA
    Anesteziol Reanimatol; 1999; (3):46-54. PubMed ID: 10458038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of febrile neutropenic patients with cancer who require hospitalization: a prospective randomized study comparing imipenem and cefepime.
    Raad II; Escalante C; Hachem RY; Hanna HA; Husni R; Afif C; Boktour MR; Whimbey EE; Kontoyiannis D; Jacobson K; Kantarjian H; Levett LM; Rolston KV
    Cancer; 2003 Sep; 98(5):1039-47. PubMed ID: 12942573
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Neutropenia with fever].
    Ben Ali A
    Presse Med; 1999 Nov; 28 Suppl 3():9-10. PubMed ID: 10605460
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cefepime plus amikacin as an initial empirical therapy of febrile neutropenia in paediatric cancer patients.
    Hamidah A; Lim YS; Zulkifli SZ; Zarina AL; Nordiah AJ; Jamal R
    Singapore Med J; 2007 Jul; 48(7):615-9. PubMed ID: 17609821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Empirical treatment of sepsis in neutropenic patients.
    Klastersky J
    Hosp Med; 2001 Feb; 62(2):101-3. PubMed ID: 11236608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Empirical antibiotic treatment of sepsis in non-neutropenic patients: single agent or combination therapy?
    Extermann M; Regamey C
    Infection; 1994; 22(1):1-3. PubMed ID: 8181835
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.